A day after the World Health Organisation (WHO) endorsed resuming trials of anti-malarial drug hydroxychloroquine (HCQ) for treatment of Covid-19 patients, chief of Council for Scientific and Industrial Research (CSIR) Shekhar C Mande on Thursday welcomed the move saying “the suspension of the trial was based on a study which had several limitations”.source https://timesofindia.indiatimes.com/india/whos-stay-on-hcq-trials-was-knee-jerk-reaction-csir-chief/articleshow/76205659.cms
Comments
Post a Comment